Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review
Int. Journal of Clinical Pharmacology and Therapeutics · 2024
DOI: 10.5414/cp204483 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Huiyi Wu und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Infections, Renal Insufficiency, Peritonitis, Pharmacy Service, Hospital. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Clinical pharmacists participated in the drug therapy of peritonitis caused by Methylobacterium infection in a patient with renal insufficiency. Based on the knowledge of clinical pharmacy, the patient's condition and laboratory parameters, the literature, and the pharmacokinetic/pharmacodynamic characteristics of antibiotics, amikacin in combination with ciprofloxacin was suggested for anti-infection therapy. During the treatment, clinical pharmacists timely evaluated the efficacy of antibiotics, monitored the adverse reactions, and provided individualized pharmaceutical care in the patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Wu, H., Chen, H., Wu, W., Zheng, P., & Li, Y. (2024). Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204483
Vancouver
Wu H, Chen H, Wu W, Zheng P, Li Y. Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204483
BibTeX
@article{Wu2024,
author = {Wu, Huiyi and Chen, Huanhao and Wu, Wenfeng and Zheng, Ping and Li, Yilei},
title = {Methylobacterium infection-induced peritonitis in a patient with renal insufficiency: A case report and literature review},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2024},
doi = {10.5414/cp204483}
}
EUVIMED